BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 7756383)

  • 1. Immunobiology and immunotherapy of melanoma.
    Mukherji B; Chakraborty NG
    Curr Opin Oncol; 1995 Mar; 7(2):175-84. PubMed ID: 7756383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunobiology of human malignant melanoma.
    Bystryn JC
    Int J Dermatol; 1980 Sep; 19(7):375-8. PubMed ID: 6998878
    [No Abstract]   [Full Text] [Related]  

  • 3. [Future of malignant stage I melanoma. Immunology and immunotherapy].
    Nicolas JF; Berthier O; Trillet-Lenoir V; Claudy A; Revillard JP
    Ann Dermatol Venereol; 1995; 122(5):324-35. PubMed ID: 8572476
    [No Abstract]   [Full Text] [Related]  

  • 4. [Passive immunotherapy of melanoma].
    Jotereau F; Labarriere N; Gervois N; Pandolfino MC; Dreno B
    Bull Cancer; 2003 Jul; 90(7):583-6. PubMed ID: 12957798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanoma vaccines.
    Perales MA; Wolchok JD
    Cancer Invest; 2002; 20(7-8):1012-26. PubMed ID: 12449735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy of melanoma.
    Parmiani G; Castelli C; Rivoltini L; Casati C; Tully GA; Novellino L; Patuzzo A; Tosi D; Anichini A; Santinami M
    Semin Cancer Biol; 2003 Dec; 13(6):391-400. PubMed ID: 15001157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunology and immunotherapy of human malignant melanoma.
    Bystryn JC
    Dermatol Clin; 1985 Apr; 3(2):327-34. PubMed ID: 2937585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redirecting human CD4+ T lymphocytes to the MHC class I-restricted melanoma antigen MAGE-A1 by TCR alphabeta gene transfer requires CD8alpha.
    Willemsen R; Ronteltap C; Heuveling M; Debets R; Bolhuis R
    Gene Ther; 2005 Jan; 12(2):140-6. PubMed ID: 15496961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunology of melanoma].
    Bröcker EB; Becker JC
    Hautarzt; 1995 Nov; 46(11):818-28. PubMed ID: 8641893
    [No Abstract]   [Full Text] [Related]  

  • 10. [A malignus melanoma immunterápiájának lehetoségei].
    Ladányi A
    Magy Onkol; 2003; 47(1):113-7. PubMed ID: 12704464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy for melanoma.
    Vaisrub S
    JAMA; 1973 Sep; 225(10):1242. PubMed ID: 4542440
    [No Abstract]   [Full Text] [Related]  

  • 12. Dissecting tumor responsiveness to immunotherapy: the experience of peptide-based melanoma vaccines.
    Mocellin S; Rossi CR; Nitti D; Lise M; Marincola FM
    Biochim Biophys Acta; 2003 Dec; 1653(2):61-71. PubMed ID: 14643925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma immunotherapy: historical precedents, recent successes and future prospects.
    Raaijmakers MI; Rozati S; Goldinger SM; Widmer DS; Dummer R; Levesque MP
    Immunotherapy; 2013 Feb; 5(2):169-82. PubMed ID: 23413908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New avenues for melanoma immunotherapy: Natural Killer cells?
    Cristiani CM; Garofalo C; Passacatini LC; Carbone E
    Scand J Immunol; 2020 Apr; 91(4):e12861. PubMed ID: 31879979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous melanoma vaccine induces antitumor and self-reactive immune responses that affect patient survival and depend on MHC class II expression on vaccine cells.
    Lotem M; Machlenkin A; Hamburger T; Nissan A; Kadouri L; Frankenburg S; Gimmon Z; Elias O; David IB; Kuznetz A; Shiloni E; Peretz T
    Clin Cancer Res; 2009 Aug; 15(15):4968-77. PubMed ID: 19602547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanoma antigens recognised by CD8+ and CD4+ T cells.
    Storkus WJ; Zarour HM
    Forum (Genova); 2000; 10(3):256-70. PubMed ID: 11007933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploiting natural killer cells for therapy of melanoma.
    Hölsken O; Miller M; Cerwenka A
    J Dtsch Dermatol Ges; 2015 Jan; 13(1):23-9. PubMed ID: 25640488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin cancer--prospects for novel therapeutic approaches.
    Stingl G
    Ernst Schering Res Found Workshop; 2000; (30):137-53. PubMed ID: 10943321
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunotherapy for melanoma: the good, the bad, and the future.
    Poehlein CH; Rüttinger D; Ma J; Hu HM; Urba WJ; Fox BA
    Curr Oncol Rep; 2005 Sep; 7(5):383-92. PubMed ID: 16091201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Immunology of Melanoma.
    Ko JS
    Clin Lab Med; 2017 Sep; 37(3):449-471. PubMed ID: 28802495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.